Source: Advances in rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, VACINAS VIRAIS, INFLUENZA
ABNT
AIKAWA, Nadia Emi et al. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus. Advances in rheumatology, v. 63, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57309. Acesso em: 08 nov. 2024.APA
Aikawa, N. E., Borba Neto, E. F., Balbi, V. A., Sallum, A. M. E., Buscatti, I. M., Campos, L. M. M. de A., et al. (2023). Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus. Advances in rheumatology, 63( 1). doi:10.1186/s42358-023-00339-7NLM
Aikawa NE, Borba Neto EF, Balbi VA, Sallum AME, Buscatti IM, Campos LMM de A, Kozu KT, Garcia CC, Capao ASV, Proença ACT de, Leon EP, Duarte AJ da S, Lopes MH, Silva CAA da, Bonfa ESD de O. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 nov. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57309Vancouver
Aikawa NE, Borba Neto EF, Balbi VA, Sallum AME, Buscatti IM, Campos LMM de A, Kozu KT, Garcia CC, Capao ASV, Proença ACT de, Leon EP, Duarte AJ da S, Lopes MH, Silva CAA da, Bonfa ESD de O. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 nov. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57309